Risk of long-term anticoagulation under sustained severe arterial hypertension: A translational study comparing warfarin and the new oral anticoagulant apixaban

Waltraud Pfeilschifter; Thurid Steinstraesser; Patrick Paulus; Pia Susan Zeiner; Ferdinand Bohmann; Alf Theisen; Edelgard Lindhoff-Last; Cornelia Penski; Marlies Wagner; Michel Mittelbronn; Christian Foerch

doi:10.1177/0271678X16642443

Risk of long-term anticoagulation under sustained severe arterial hypertension: A translational study comparing warfarin and the new oral anticoagulant apixaban

Waltraud Pfeilschifter, Thurid Steinstraesser, Patrick Paulus, Pia Susan Zeiner, Ferdinand Bohmann, Alf Theisen, Edelgard Lindhoff-Last, Cornelia Penski, Marlies Wagner, Michel Mittelbronn, Christian Foerch

Faculty of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Number of pages	11
Journal	Journal of Cerebral Blood Flow and Metabolism
Volume	37
Issue number	3
DOIs	https://doi.org/10.1177/0271678X16642443
Publication status	Published - 2017

Fields of science

301 Medical-Theoretical Sciences, Pharmacy

JKU Focus areas

Health System Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1177/0271678X16642443

Cite this

Pfeilschifter, W., Steinstraesser, T., Paulus, P., Zeiner, P. S., Bohmann, F., Theisen, A., Lindhoff-Last, E., Penski, C., Wagner, M., Mittelbronn, M., & Foerch, C. (2017). Risk of long-term anticoagulation under sustained severe arterial hypertension: A translational study comparing warfarin and the new oral anticoagulant apixaban. Journal of Cerebral Blood Flow and Metabolism, 37(3). https://doi.org/10.1177/0271678X16642443

@article{81b65059eaa143ae94889e2910cc4c25,

title = "Risk of long-term anticoagulation under sustained severe arterial hypertension: A translational study comparing warfarin and the new oral anticoagulant apixaban",

author = "Waltraud Pfeilschifter and Thurid Steinstraesser and Patrick Paulus and Zeiner, \{Pia Susan\} and Ferdinand Bohmann and Alf Theisen and Edelgard Lindhoff-Last and Cornelia Penski and Marlies Wagner and Michel Mittelbronn and Christian Foerch",

year = "2017",

doi = "10.1177/0271678X16642443",

language = "English",

volume = "37",

journal = "Journal of Cerebral Blood Flow and Metabolism",

issn = "0271-678X",

publisher = "Sage",

number = "3",

}

Pfeilschifter, W, Steinstraesser, T, Paulus, P, Zeiner, PS, Bohmann, F, Theisen, A, Lindhoff-Last, E, Penski, C, Wagner, M, Mittelbronn, M & Foerch, C 2017, 'Risk of long-term anticoagulation under sustained severe arterial hypertension: A translational study comparing warfarin and the new oral anticoagulant apixaban', Journal of Cerebral Blood Flow and Metabolism, vol. 37, no. 3. https://doi.org/10.1177/0271678X16642443

Risk of long-term anticoagulation under sustained severe arterial hypertension: A translational study comparing warfarin and the new oral anticoagulant apixaban. / Pfeilschifter, Waltraud; Steinstraesser, Thurid; Paulus, Patrick et al.
In: Journal of Cerebral Blood Flow and Metabolism, Vol. 37, No. 3, 2017.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Risk of long-term anticoagulation under sustained severe arterial hypertension: A translational study comparing warfarin and the new oral anticoagulant apixaban

AU - Pfeilschifter, Waltraud

AU - Steinstraesser, Thurid

AU - Paulus, Patrick

AU - Zeiner, Pia Susan

AU - Bohmann, Ferdinand

AU - Theisen, Alf

AU - Lindhoff-Last, Edelgard

AU - Penski, Cornelia

AU - Wagner, Marlies

AU - Mittelbronn, Michel

AU - Foerch, Christian

PY - 2017

Y1 - 2017

UR - http://www.ncbi.nlm.nih.gov/pubmed/27189904

U2 - 10.1177/0271678X16642443

DO - 10.1177/0271678X16642443

M3 - Article

SN - 0271-678X

VL - 37

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

IS - 3

ER -

Risk of long-term anticoagulation under sustained severe arterial hypertension: A translational study comparing warfarin and the new oral anticoagulant apixaban

Fields of science

JKU Focus areas

UN SDGs

Access to Document

Other files and links

Cite this